Replies to post #36692 on OncoSec Medical Inc (ONCSQ)

[Waitforit53]

So when I listen to Dr. Gargosky speak of amending the phase 2B trial, it sounds as though the protocol she was looking to amend would be to include information from patients who had prior failed chemo, immuno, or radiation therapy. And that they were going to enter into discussions to see if that were possible for the remaining months of this trial. It can't relate to patient recruitment because they believe the clinical trial will be fully enrolled by end of calendar year this year. Is that an adequate take away from your comments?

I am also assuming by the way she is impressed with the data – – that it appears these nonresponders are generating a favorable remission to the tumors regardless of the type of prior treatment they have had.